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Value of tissue harmonic imaging (THI)
and contrast harmonic imaging (CHI)
in detection and characterisation
of breast tumours
Abstract The purpose of this study
was to investigate the extent to which
tissue harmonic imaging (THI),
speckle reduction imaging (SRI),
spatial compounding (SC) and con-
trast can improve detection and dif-
ferentiation of breast tumours. We
examined 38 patients (14 benign, 24
malignant tumours) with different
combinations of THI, SRI and SC.
The effect on delineation, margin,
tissue differentiation and posttumoral
phenomena was evaluated with a
three-point score. Additionally, 1oo
not palpable tumours (diameters:
4–15 mm) were examined by contrast
harmonic imaging (CHI) with power
Doppler. After bolus injection (0.5 ml
Optison), vascularisation and en-
hancement were observed for 20 min.
The best combination for detection of
margin, infiltration, echo pattern and
posterior lesion boundary was the
combination of SRI level 2 with SC
low. THI was helpful for lesions OF
more than 1 cm depth. In native Power
Doppler, vessels were found in 54 of
100 lesions. Within 5 min after con-
trast medium (CM) injection, marginal
and penetrating vessels increased in
benign and malignant tumours and
central vessels mostly in carcinomas
(p<0.05). A diffuse CM accumulation
was observed up to 20 min after
injection in malignant tumours only
(p<0.05). THI, SRI and SC improved
delineation and tissue differentiation.
Second-generation contrast agent al-
lowed detection of tumour vasculari-
sation with prolonged enhancement.
Keywords Breast ultrasound . Tissue
harmonic imaging . Spatial
compounding . Contrast harmonic
imaging
Introduction
As a technique complementary to mammography, high-
resolution ultrasound (US) is well accepted for differentiat-
ing between cystic and noncystic putative tumour lesions
[1–11]. New developments such as tissue harmonic
imaging (THI) and contrast harmonic imaging (CHI)
have enhanced its value, particularly for primary detecting
tumours in dense inhomogeneous mammary gland tissue,
identifying mammographically occult tumours and ap-
praising abnormalities in tissue architecture [8, 12–22].
Lesions that are only a few millimetres in size become
detectable, and tumours can be characterised more pre-
cisely. Ultimately, the exact localisation of small tumours is
a prerequisite for ultrasound-guided needle biopsy, vacuum
biopsy or preoperative wire placement [15, 23–25].
Harmonic imaging allows better visualisation of tissue
architecture and facilitates recognition of parenchymal
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mark small lesions with THI [19, 26, 27].
For tumour characterisation, it is also essential to
appraise vascularisation in a manner comparable to that
achieved by dynamic contrast-medium-enhanced magnetic
resonance imaging (MRI) [4, 12, 16, 17, 28–31]. Even if
computed evaluation programmes with pixel analysis
facilitate appraisal of tumour blood flow, native vascular
US with power Doppler (PD) has proved to be relatively
unreliable [4, 9, 13, 17, 18, 23, 24, 29]. Contrast medium
enhancement already enables more distinct visualisation of
intratumoral and peritumoral vessels. However, the brief
diagnostic time window after bolus injection of US contrast
medium (CM) is often a limiting factor. The combination
of CHI with PD opens up promising vistas for appraisal of
vascularisation. Preliminary investigations indicate that
tumour detection, characterisation and US-guided inter-
vention can be improved by using a CM of the second
generation with modified CHI technique [18, 25, 32]. The
aim of our study was to evaluate their potential benefits and
limitations for detecting and differentiating breast tumours.
Materials and methods
Patients and US
A total of 138 patients (age: 25–79 years, median 54 years)
were investigated in a multicentre trial with complementary
mammary diagnostic procedures over a 36-month period
(November 2002 to November 2005). All women gave
informed written consent for their results to be used for
programme research and evaluation. On the basis of US
findings, each lesion was evaluated based on size, shape
(ellipsoid, round, irregular), margins (smooth, macrolobu-
lated, microlobulated, speculated, angulated, ill-defined),
posterior sonographic artefacts (shadowing, through trans-
mission, no posterior artefacts), echogenicity (hyperecho-
genic, isoechoic, hypoechoic), presence of calcifications
and ductal extension. Investigations were supplemented by
clinical examination and mammography in two planes.
Ultrasound lesions were examined in three planes using PD
and digital imaging with the GE Logiq 9 (GE Medical
Systems, Milwaukee, WI, USA) US units. All investiga-
tions were carried out with a high-resolution multi-
frequency linear matrix array transducer (Linear Array
M10L, 5–10 MHz) with the modalities of THI, spatial
compounding (crossbeam), speckle reduction imaging
(SRI) and contrast-medium-enhanced PD with CHI and
additional three-dimensional (3D) imaging. Imaging doc-
umentation of digital raw data in single-image and short
sequences was effected using a Picture and Communica-
tion System (PACS).
Study population
The patient population was divided into two groups. In
group 1, we focused on the advantage of THI, SC and an
adaptive algorithm for SRI. In group 2, we focused on CHI
with PD.
Group 1
Thirty-eight patients (37–62 years) with 14 benign and
24 malignant tumours were examined in fundamental
mode and with harmonic imaging with a high-frequency
matrix-array transducer with the modalities of THI, SC and
an adaptive algorithm for SRI. Prospectively, fundamental
and tissue harmonic mode were used alone and in
combination with all available levels of SC (cross beam:
low, medium, high, maximum) and five levels of SRI. In
patients without tumour lesions, criteria were differentia-
tion of normal fibroglandular tissue from premammary and
retromammary fat, including the Cooper’s ligaments and
ducts. Criteria that were evaluated for differential diagnosis
in patients with lesions were margin, infiltration of
malignant tumours, echo pattern with tissue components,
calcifications, posterior lesion boundary and posterior
acoustic features. After optimising system settings, a
three-level score was applied to enable comparison of the
quality of scans with fundamental imaging (0=equal, −1=
inferior, +1=superior).
Group 2
One hundred patients (25–76 years, median 53 years)
comprised 29 probably benign [Breast Imaging Reporting
and Data System (BI-RADS III)] and 71 malignant (BI-
RADS IV–V) tumours confirmed by vacuum-assisted
biopsy in 100/100 lesions and 78/100 cases additionally in
the course of surgery. Tumour diameters varied between 4
and 15 mm (mean: 9 mm). Histological confirmation was
obtained in all cases. All patients were comparatively
investigated with fundamental B scan, THI and CHI with
PD. After the B scan and evaluation of vascularisation in
native PD, we used an echo signal amplifier of the second
generation with low mechanical index (MI) technology. A
bolus injection of Optison was administered (0.5 ml
Optison diluted with 20 ml with NaCl solution and
subsequent injection of another 20 ml NaCl). The bolus
of CM was injected intravenously, and spreading of the
contrast enhancement and washout in the tumours were
followed for at least 20 min. A low MI (0.15–0.25) was
chosen to avoid early destruction of the microbubbles.
CM enhancement was appraised for up to 20 min.
Moreover, additional 3D evaluations of the cine sequences
were also possible retrospectively in consequence of the
archiving of dynamic digital images of up to 180 single
2images and 10- loop. The images archived in B scan and
THI could also be processed retrospectively, with various
phases of SRI, which enabled marginal contours of the
tumours to be highlighted by homogenising tissue struc-
tures. The patients were given detailed information before
each injection of CM, particularly with respect to a possible
predisposition to allergic reactions. Written consent was
obtained. Studies were performed only in patients with
normal renal function. Approval had been obtained from
the hospital’s ethics committee.
Histopathological correlation
Histopathological correlation was determined based on
surgical and biopsy findings. Tumour size, grade, histol-
ogical subtype and presence of invasion were documented.
Pathological imaging correlation was performed in con-
junction with both pathologist and breast imagers with
regard to lesion location and size to ensure that the imaged
lesions were evaluated histologically.
Breast biopsy
US-guided biopsies were performed as vacuum-assisted
biopsies, mostly with an 11-gauge needle. Up to 12
representative tissue samples were taken. When there were
malignant findings, US-guided wire marking was mostly
undertaken before surgical excision. Afterwards, follow-up
examinations were carried out at 6-month intervals.
Statistical analysis
We carried out statistical analyses:
1. Elementary statistics were computed.
2. Fisher’s two-tailed exact test was applied for statistical
assessment of powers for discriminating different
vascularisation and comparison of benign tumours
versus carcinomas after the use of Optison.
Results
Group1
THI has no effect on image quality in the near field. THI
needs at least 1 cm of tissue penetration. The effect is best
seen in the middle and far field, especially around the focus
zone. Cutis and the first 10 mm of fat and Cooper’s
ligaments are already seen in fundamental mode, with
better visibility and delineation with SC (cross beam: level
medium) and SRI. The reflex of the anterior mammary
fascia appears thinner and brighter with SC (cross beam:
level medium to high) than in fundamental imaging. Ducts
in deeper areas are best visualised with a combination of
SC and THI. The main disadvantage is a significant
reduction of the frame rate caused by SC, especially when
THI is possible in addition. The first impression from
image analysis of all combinations of SC and SRI was that
higher levels of SC could be avoided by using, in addition,
an SRI level of 1 or 2, giving the same advantage over the
Fig. 1 Effect on delineation
of tumour margin and tissue
differentiation. On the left side
is fundamental mode without
spatial averaging and tissue
harmonic imaging (THI). On the
right side THI+cross beam level
low+speckle reduction imaging
(SRI) 2. a Improvement of
delineation of tumour margin,
especially if the tumour border
is perpendicular to the ultra-
sound beam (fibroadenoma).
b Improvement of tissue differ-
entiation (haematoma)
3fundamental image with less reduction of frame rate. The
best compromise for screening examinations of breast
tissue is the combination of SC (level low) and SRI (level 1
or 2) with THI in small breasts. Fat appears slightly more
echogenic, which potentially helps to define small tumours.
The main limitation of THI was the reduced penetration
(16% of our patients). In patients with large breasts and
abundant fibrous tissue, fundamental imaging should be
preferred.
Lesion detection and differentiation
In four out of five cysts, THI clears artifactual echoes
caused by reverberations, noise and speckle so that even
small intracystic lesions could be depicted. Best visibility
was achieved with a combination of THI, SC (level low)
and SRI 2, giving clear cyst borders and the intracystic
lesion. Using SC in two out of five cysts, the typical dorsal
enhancement caused by sound transmission is less intense,
as expected from the fundamental mode. Fibroadenomas
were best detected with a combination of THI with SC
(level medium) and SRI (2), showing better margin
delineation, even in the edges. Better differentiation of
tissue components and tumour infiltration could be
achieved by the same combination (Fig. 1). Solid nodules
generally appear more hypoechoic compared with sur-
rounding breast tissue, which affords a better chance of
detection [33].
Calcifications detected in mammography were seen in
US in six out of ten patients. Visibility was increased,
especially after using the combination of THI and SRI or
SC and SRI (Fig. 2a,b). Results for malignant tumours are
summarised in Table 1.
Group 2
Seventy-one cases confirmed by biopsy were classified as
malignant (BI-RADS IV–V), and 29 cases were cate-
gorised as most likely benign (BI-RADS III). Histological
confirmation by vacuum biopsy was also performed at
patients’ expressed request and in cases of malignancy or
borderline lesions also by surgery (82/100).
Histological appraisal
Benign lesions
Histological finding detected four cases with a scar or
intraductal inflammatory origin or ductal lesions, two cases
of papillomas, five cases of fibrocystic mastopathy and 18
cases of fibroadenomas.
Fig. 2 a, b Effect on visibility
of calcifications and delineation
of tumour margin a Fundamen-
tal B mode. b Tissue harmonic
imaging (THI)+cross beam
low+speckle reduction imaging
(SRI) level 1. Well-differen-
tiated invasive ductal carcinoma
with microcalcification and
infiltration better seen in cross
beam+SRI 2. There is less
attenuation retrotumoral due to
spatial compounding (SC)
4Malignant lesions
Histological findings revealed 11 ductal carcinomas in situ
(DCIS), two lobular carcinomas in situ (LCIS) and 58 cases
of ductal invasive carcinomas. Sonomorphology defined in
particular the extent of the tumour, marginal contours,
change in tissue architecture, possible infiltration of sur-
rounding tissue, intraductal spreading, altered echogenicity
of lesions with possible dorsal sound enhancement or
attenuation and unchanged compressibility. In PD, CM
enhancement with harmonic imaging additionally enabled
detection of peritumoral or intratumoral and irregular
vessels penetrating the tumour as well as increased tumour
vascularisation in intermittent dynamic appraisal. In par-
ticular, irregular penetrating vessels and prolonged en-
hancement for more than 5 min were found in only
malignancies (65/71 cases: Fig. 3a–d, Fig. 4a–d and
Fig. 5a–f). In six cases of DCIS with a maximum diameter
of 5 mm and low grading (G I), increased vascularisation
could not be demonstrated, even after CM enhancement.
All were detected as small lesions using a combination of
THI with SC. Five out of six showed tiny peritumoral
vessels after contrast administration. Proliferating fibroa-
denomas and scars may show an increased peritumoral
vascularisation but did not show prolonged enhancement in
harmonic imaging with PD (Table 2).
The results of our own investigations indicate that the
tumours can be identified better during biopsy in echo-
inhomogeneous tissue using CHI in biopsies of smaller
tumours under 10 mm in size. This enables false negative
findings to be avoided in the histopathological investiga-
tions. After injection of CM, satellite foci and lymph nodes
may also show increased vascularisation, which is mani-
fested especially in harmonic imaging with PD.
Discussion
After clinical examination, breast US is the preferred
method in symptomatic patients. In cases without symp-
toms,breastUSisascribed ahighersensitivity fordetecting
breast cancer in women with dense breast tissue, women
under the age of 50 and high-risk women. Mammographi-
cally occult cancers can be detected by US in 10–40% of
cases, depending on patients’ breast density and age. For
Fig. 3 a–d Well-differentiated
invasive ductal carcinoma
(75-year-old woman, non-pal-
pable mass) a Irregular tumour
of 12 mm with hidden distal
border in fundamental B scan
and tissue harmonic imaging
(THI). b, c In combination with
cross beam and speckle reduc-
tion imaging (SRI), better deli-
neation of the pectoral (distal)
aspect , in particular, showing
infiltration of the pectoral fascia.
d Good visibility of the biopsy
needle in THI and THI with
crossbeam in three-dimensional
(3D) technique
Table 1 Results of comparison of fundamental versus combination
of tissue harmonic imaging (THI), spatial compounding (SC) (cross
beam: level low) and speckle reduction imaging (SRI) level 1
Criteria −10 + 1
Margin 1 11 12
Infiltration (existent in 19/24 malignant cases) 1 3 15
Echo pattern/tissue components 3 10 11
Calcifications 1 2 3
Posterior lesion boundary 1 7 16
Posterior acoustic features 9 9 6
Score : −1=fundamental superior, 0=no difference, +1=combination
superior
5women without symptoms, breast US should be mandatory
and complementary to mammography in the case of breast
densitygradeII[AmericanCollegeofRadiology(ACR)]or
more [34]. US is now the more accurate imaging test in
women 45 years or younger who present with breast
symptoms and should be the initial imaging investigation
[5, 7, 35]. In preoperative assessment of the local extent of
breast cancer, US showed higher sensitivity for invasive
cancerthanforDCIS[8,35,41].Innonfattybreasts,USand
MRI were more sensitive than mammography for detecting
invasive cancer, but both MRI and US involved the risk of
overestimating tumour extent [4, 7–9, 12, 35]. Mammo-
graphic sensitivity decreased from 100% in fatty breasts to
45% in extremely dense breasts.
Therespective diagnostic accuracy of the different breast
imaging modalities, i.e. mammography (Mx), high-resolu-
tion breast US, and dynamic contrast-enhanced breast
scanning (MRI) regarding early diagnosis of familial
(hereditary) breast cancer were investigated. Breast cancer
detection rates were: Mx: 42%, US 25% and MRI 83%,
and positive predictive values were: Mx 29%, US 30% and
MRI 43% [8].
THI in combination with digital encoding of the US
beam is an increasingly common option for B-mode
imaging. It reduces reverberations, sidelobe effects and
speckle. Both image contrast and lateral resolution are
improved in harmonic mode compared with conventional
fundamental US [36]. First applications are reported for
liver disease [37], lymph node enlargement in children [38]
and patients with pancreatitis. Benefits of harmonic
imaging are more apparent in obese patients, improving
accuracy of diagnosis from 60% to 80% [39]. To determine
the impact of THI on visualisation of focal breast lesions,
Szopinski et al. [21] performed a prospective study on 219
female patients. THI improved the grey scale contrast
between fatty tissue and breast lesions in 230 lesions
(90.6%; p<0.001) compared with fundamental frequency
images. Contrast improvement was greater in breasts with
predominantly fatty or mixed (fatty/glandular) composition
than in predominantly glandular breasts. Overall conspicu-
ousness, lesion border definition, lesion content definition
and acoustic shadow conspicuousness were improved or
equal in the harmonic mode for all lesions.
After optimising the system settings, our results showed
better delineation of tumour borders and infiltration with
the combination of SC and SRI. Better differentiation of
tissue structure was seen in the combination of THI and
SRI; microcalcifications could be depicted best with a
combination of harmonic mode, SRI and SC [19, 27, 40].
Retrotumoral tissue and the posterior lesion boundary of
tumours are significantly better identified with high values
of SC. One must be aware of the potential problem that the
typical posterior acoustic enhancement is significantly
reduced, with the result that a cyst can be misinterpreted as
a solid tumour.
THI and CHI can be helpful for detecting tumours less
than 10 mm in size in echo-inhomogeneous dense tissue,
for characterising tumour morphology with dynamic
enhancement studies and for performing a definitive core
needle biopsy or vacuum-assisted biopsy in cases of
Fig. 4 a–d Same patient as
Fig. 3 with invasive ductal car-
cinoma. a Unenhanced power
Doppler (PD) shows few
peripheral vessels. b–c After
administration of 0.5 ml Option,
increasing enhancement within
the lesion with prolonged per-
sistence of enhancement up to
6 min is seen. d Beginning
washout after 8 min
6tumour lesions less detectable in fundamental B scan or
tumours located in the deep tissue near the intercostal
muscles. Harmonic imaging in combination with SRI and
cross beam can facilitate detection of intraductal tumours
such as papillomas. With 3D imaging, the needle could be
more easily placed in the middle of these small intraductal
tumours during biopsies [15].
Various criteria of image morphology have proved
useful in appraising whether a breast tumour is benign or
malignant on the basis of US. Smooth marginal contour,
dorsal US amplification, displacement margin, bilateral US
extinction and absence of structural discontinuity in that
order rather indicate a benign lesion. An echodense border,
tumour outliers, jagged marginal contour, dorsal extinction
and structural discontinuity point to malignant lesions. In
consequence of the increasing improvements in tumour
detection and morphological imaging, sensitivity <80%
and specificities <95% can be achieved with US in tumour
diagnostics [5, 7, 20, 21, 35]. An even higher diagnostic
certainty is aspired to. This can already be attained with the
Fig. 5 a, b Ductal carcinoma in
situ (DCIS) (35-year-old
woman, no palpable mass).
Cervical carcinoma, breast
cancer in mother and sister. No
clinical signs. Tumour proven
by vacuum-assisted biopsy
(DCIS) a Fundamental (B scan).
b Tissue harmonic imaging
(THI) showing a small, distinct,
irregular mass of 8 mm.
c–f Same patient as a, b. c
Power Doppler (PD) before
administration of contrast.
d Pronounced visibility of the
feeding vessel in the early
phase. e Late and persistent
enhancement of the tumour
typical for malignant breast
tumours. f Better delineation of
the tumour even after 14 min in
contrast harmonic imaging
(CHI) mode
7combination of mammography and breast US, especially in
dense and inhomogeneous glandular tissue [2, 7, 22, 35].
Tumour lesions of BI-RADS IV and V have to be
clarified by biopsy, in particular, punch biopsy or vacuum
biopsy. Consequently, US-guided biopsy is appropriate
when it allows unequivocal lesion identification. US-
guided interventions are required for further clarification in
mammography occult findings and preoperative wire
marking. In our own investigations, harmonic imaging
was employed for definitive preoperative wire marking, to
carry out a US-guided vacuum biopsy and also with CM
enhancement for improved tumour detection.
Additional Doppler methods have been used to analyse
breast tumour vascularity [42, 43]. Detection of penetrating
or central vessels proved to be an accurate sign of malig-
nancy [12, 13, 17, 22, 24, 25, 29, 31]. With the application
of CM (Levovist), additional vessels were detected within
the lesions, increasing diagnostic accuracy. Sensitivity of
colour-coded US was improved from 64% up to 86% using
the echo signal amplifier. Specificity was 86% without and
82% with echo signal amplifier. MRI was found to have a
sensitivity of 100% and a specificity of up to 82% [12].
Our study with a modified technique of CM-enhanced
PD and THI showed better visualisation of tumour
vascularisation after bolus application of Optison. Persis-
tent enhancement after 5 min was characteristic for
malignant tumours, enabling tumour characterisation as
has hitherto only been known from CM-enhanced MRI
[4, 12, 16, 18, 24, 29–31, 44].
When using CM containing protein, special attention
must be paid to an allergic predisposition and kidney
function disorder. The use of second-generation CM
necessitates a change in MI and imaging with harmonic
imaging. However, the modified technique allows a
differentiated diagnosis of tumour morphology and vascu-
larisation [4, 12, 25, 29, 44, 45].
To improve the detection and assessment of intratumoral
vessels in malignant breast tumours, techniques to enhance
visualisation of vessels within focal lesions have been
developed and automated. These techniques focus on the
early perfusion phase following CM administration. Con-
trast-enhanced MRI allowed semiquantitative assessment
of the kinetics of contrast media [4, 18, 31]. Artefacts
caused by pulsation and patient movement should be
avoided. More frequently, 3D postprocessing has become
important in assessment of vasculature. CHI US is already
used to distinguish scars from recurrent tumours as well as
in the optimisation of US-guided biopsies [14, 15, 20, 32].
Conclusion
In conclusion, we feel confident that US using THI and
CHI technologies is a valuable tool for evaluating focal
breast lesions, in particular in mammography-dense
breasts. If utilised extensively, it will be a cost-effective
tool to facilitate detection and differentiation of malignant
breast lesions in early, well-treatable stages and will thus
help in reducing breast cancer mortality.
Table 2 Comparison of benign tumours versus carcinomas. Vascularisation after administration of CM [0.5 ml Optison]
Benign tumours (n=29) Carcinomas (n=71)
Power Doppler Power Doppler +CM Power Doppler Power Doppler + CM
Early phase (1–5 min)
Marginal vessels 11/29 (38%) 24/29 (83%) 43/71 (60%) 67/71 (94%)
Penetrating vessels 4/29 (14%) 12/29 (41%) 28/71 (39%) 65/71 (91%) (p<0.05)
Central vessels 0/29 (0%) 6/29 (20%) 21/71 (29%) 48/71 (68%) (p<0.05)
Late phase (5–20 min)
Diffuse enhancement 0/29 0/29 0/71 65/71 (91%) (p<0.01)
Marginal vessels are seen in both groups in a high percentage. Most carcinomas show diffuse enhancement through the late phase
(statistical evaluation with the Fisher’s exact test, significant differences p<0.05)
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